945
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Design, synthesis and preliminary activity evaluation of novel 3-amino-2-hydroxyl-3-phenylpropanoic acid derivatives as aminopeptidase N/CD13 inhibitors

, , , , , & show all
Pages 545-551 | Received 06 Sep 2011, Accepted 07 Jan 2012, Published online: 01 Mar 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Patrick E. Hanna & M. W. Anders. (2019) The mercapturic acid pathway. Critical Reviews in Toxicology 49:10, pages 819-929.
Read now

Articles from other publishers (6)

Oldřich Farsa, Veronika Ballayová, Radka Žáčková, Peter Kollar, Tereza Kauerová & Peter Zubáč. (2022) Aminopeptidase N Inhibitors as Pointers for Overcoming Antitumor Treatment Resistance. International Journal of Molecular Sciences 23:17, pages 9813.
Crossref
Atsushi Tarui, Masakazu Ueo, Marino Morikawa, Masahiko Tsuta, Sumika Iwasaki, Noriko Morishita, Yukiko Karuo, Kazuyuki Sato, Kentaro Kawai & Masaaki Omote. (2020) One-Pot Ring-Opening Peptide Synthesis Using α,α-Difluoro-β-Lactams. Synthesis 52:23, pages 3657-3666.
Crossref
Yue Yang, Jiangwei Hu, Hao Fang, Xuben Hou, Zhun Hou, Lihong Sang & Xinying Yang. (2020) Enantioseparation of lysine derivatives on amylose tris (3, 5-dimethylphenylcarbamate) as chiral stationary phase with high separation factor. Journal of Chromatography A 1632, pages 461598.
Crossref
Sk. Abdul Amin, Nilanjan Adhikari & Tarun Jha. (2018) Design of Aminopeptidase N Inhibitors as Anti-cancer Agents. Journal of Medicinal Chemistry 61:15, pages 6468-6490.
Crossref
Shilvi Joshi, Lang Chen, Michael B. Winter, Yi-Lun Lin, Yang Yang, Mariya Shapovalova, Paige M. Smith, Chang Liu, Fang Li & Aaron M. LeBeau. (2017) The Rational Design of Therapeutic Peptides for Aminopeptidase N using a Substrate-Based Approach. Scientific Reports 7:1.
Crossref
MIKIKO AOKI, KAZUKI NABESHIMA, HIROYUKI HAYASHI, MAKOTO HAMASAKI & HIROSHI IWASAKI. (2013) Identification of APN/CD13 as the target antigen of FU3, a human monoclonal antibody that recognizes malignant fibrous histiocytoma. International Journal of Oncology 43:1, pages 57-62.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.